Summary:
The major goal of the World Marrow Donor Association (WMDA) is to facilitate the transfer of hematopoietic cells for transplantation purposes across international borders. It also has the goal of establishing guidelines on ethical, technical, medical, and financial aspects that concern the donor and donor-cell transfer. It has a Board and five Working Groups, namely the Donor Registry Working Group, the Quality Assurance Group, the Ethic Working Group, the Finance Working Group, and the Clinical Working Group. It has three types of membership, that is, full organizational membership, nonvoting organizational membership, and individual corresponding membership. Current important projects are speeding up the search process, accreditation of registries and collecting information about severe adverse effects in donors.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
The Executive Committee of the World Marrow Donor Association. Special report: Bone marrow transplants using volunteer donors – recommendations and requirements for a standardized practice throughout the world. Bone Marrow Transplant 1992; 10: 287–291.
Goldman JM, Cleaver S, Warren P . World Marrow Donor Association: a progress report. Bone Marrow Transplant 1994; 13: 689–691.
Gahrton G . Goals and activities of the WMDA. World Marrow Donor Association. Int J Hematol 2002; 76 (Suppl. 1): 384–385.
Thomas E, Storb R, Clift RA et al. Bone-marrow transplantation (first of two parts). N Engl J Med 1975; 292: 832–843.
Thomas ED, Storb R, Clift RA et al. Bone-marrow transplantation (second of two parts). N Engl J Med 1975; 292: 895–902.
Hansen J, McCullough J . Alternative donors – unrelated donor BMT. In: Champlin RE, Gale RP (eds). New Strategies in Bone Marrow Transplantation. Wiley-Liss: New York, 1991, pp 453–457.
Goldman JM . A special report: bone marrow transplants using volunteer donors – recommendations and requirements for a standardized practice throughout the world – 1994 update. The WMDA Executive Committee. Blood 1994; 84: 2833–2839.
Hurley CK, Wade JA, Oudshoorn M et al. Histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors: report from The World Marrow Donor Association. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. Bone Marrow Transplant 1999; 24: 119–121.
Cleaver SA, Warren P, Kern M et al. Donor work-up and transport of bone marrow – recommendations and requirements for a standardized practice throughout the world from the Donor Registries and Quality Assurance Working Groups of the World Marrow Donor Association (WMDA). Bone Marrow Transplant 1997; 20: 621–629.
Hurley CK, Schreuder GM, Marsh SG, Lau M, Middleton D, Noreen H . The search for HLA-matched donors: a summary of HLA-A*, -B*, -DRB1/3/4/5* alleles and their association with serologically defined HLA-A, -B, -DR antigens. Tissue Antigens 1997; 50: 401–418.
Hurley CK, Wade JA, Oudshoorn M et al. A special report: histocompatibility testing guidelines for hematopoietic stem cell transplantation using volunteer donors. Quality Assurance and Donor Registries Working Groups of the World Marrow Donor Association. Hum Immunol 1999; 60: 347–360.
Schreuder GM, Hurley CK, Marsh SG et al. The HLA dictionary 1999: a summary of HLA-A, -B, -C, -DRB1/3/4/5, -DQB1 alleles and their association with serologically defined HLA-A, -B, -C, -DR and -DQ antigens. Tissue Antigens 1999; 54: 409–437.
Bakken R, van Walraven A, Egeland T on behalf of the Ethics Working Group of the World Marrow Donor Association. Donor commitment and patients needs. Bone Marrow Transplant 2003; submitted.
Rosenmayr A, Hartwell L, Egeland T on behalf of the Ethics Working Group of the World Marrow Donor Association. Informed consent suggested procedures for informed consent for unrelated hematopoietic stem cell donors at various stages of recruitment, donor evaluation and donor workup. Bone Marrow Transplant 2003; 31: 531–537.
Egeland T, Lie J, Persson U on behalf of the World Marrow Donor Association (WMDA) Ethics Working Group and Raymond J, and Müller C, WMDA Finance Working Group. Donor and liability insurance of donor registries, donor centers and collection centers. Bone Marrow Transplant 2003; submitted.
Marry E, Oudshoorn M (eds). Donor Registries Annual Report 2001, 5th edn. WMDA: Netherlands, 2002.
Oudshoorn M (ed). Unrelated Cord Blood Registries/Banks. Annual Report 2001, 3rd edn. WMDA, NetCord: Netherlands, 2001.
Bensinger WI MP, Storer B, Clift R et al. Transplantation of bone marrow as compared with peripheral blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344: 175–181.
Gahrton G, Svensson H, Cavo M et al. Progress in allogenic bone marrow and peripheral blood stem cell transplantation for multiple myeloma: a comparison between transplants performed 1983–93 and 1994–8 at European Group for Blood and Marrow Transplantation centres. Br J Haematol 2001; 113: 209–216.
Gahrton G AJ, Bacigalupo A, Björkstrand B et al. An update of allogeneic transplantation with peripheral blood stem cells (PBSCT) as compared to bone marrow (BMT) in multiple myeloma. Bone Marrow Transplant 2001; 29 (Suppl. 2): S13.
Author information
Authors and Affiliations
Consortia
Rights and permissions
About this article
Cite this article
Gahrton, G., van Rood, J., Oudshoorn, M. et al. The World Marrow Donor Association (WMDA): its goals and activities. Bone Marrow Transplant 32, 121–124 (2003). https://doi.org/10.1038/sj.bmt.1704097
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.bmt.1704097